VEGF and Colorectal Cancer Prognosis
Author Information
Author(s): S-I Ishigami, S Arii, M Furutani, M Niwano, T Harada, M Mizumoto, A Mori, H Onodera, M Imamura
Primary Institution: First Department of Surgery, Faculty of Medicine, Kyoto University, Kyoto, Japan
Hypothesis
The study investigates the association of VEGF mRNA expression with the progression and metastasis of human colorectal cancer.
Conclusion
Higher levels of VEGF mRNA expression in colorectal cancer are associated with poorer patient prognosis and increased metastatic potential.
Supporting Evidence
- Patients with overexpression of VEGF mRNA demonstrated poorer survival than those without.
- The VEGF T/N ratio was significantly correlated with the depth of tumor infiltration.
- Patients with synchronous liver metastasis had a higher VEGF T/N ratio.
Takeaway
This study found that a substance called VEGF in cancer cells can help predict how well patients with colorectal cancer will do after treatment.
Methodology
VEGF mRNA expression was quantified using Northern blot hybridization in tumorous and non-tumorous tissues from colorectal cancer patients.
Participant Demographics
40 men and 20 women, age range 43-90 years, mean age 65.3 years.
Statistical Information
P-Value
P < 0.0001
Confidence Interval
1.23-3.06
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website